Preview

Experimental and Clinical Gastroenterology

Advanced search

Steatotic liver disease - an international interpretation of the concept an “umbrella” for all diseases of the hepatic parenchyma

https://doi.org/10.31146/1682-8658-ecg-216-8-24-26

Abstract

The international working group “Multi-Society and Multi-Stakeholder Consensus Revision of the NAFLD Nomenclature” proposed to replace the widely used term NAFLD - Non-alcoholic fatty liver disease with SLD - Steatotic Liver Disease - Steatous Liver Disease, using it in the form of an “umbrella” to include in this concept Metabolic and Alcoholic liver disease, its drug lesions and severe systemic diseases of the hepatic parenchyma.

About the Author

L. B. Lazebnik
A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation


References

1. Eslam M., Newsome P. N., Sarin S. K., Anstee Q. M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039.

2. Eslam M., Sanyal A. J., George J.; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

3. Younossi Z. M., Rinella M. E., Sanyal A. J., Harrison S. A., Brunt E. M., Goodman Z., Cohen D. E., Loomba R. From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420.

4. Rinella M. E., Lazarus J. V., Ratziu V. et al.; NAFLD Nomenclature consensus group. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Jun 24. doi: 10.1097/HEP.0000000000000520.

5. Ratziu V., Rinella M., Beuers U., Loomba R., Anstee Q. M., Harrison S., Francque S., Sanyal A., Newsome P. N., Younossi Z. The times they are a-changin’ (for NAFLD as well). J Hepatol. 2020 Dec;73(6):1307-1309. doi: 10.1016/j.jhep.2020.08.028.

6. Kotsiliti E. Hybrid EASL Congress 2023. Nat Rev Gastroenterol Hepatol. 2023 Jul 27. doi: 10.1038/s41575-023-00823-x.

7. Lazebnik L. B., Turkina S. V. Enterohepatocentrism as the basis of human psychosomatic pathology. Experimental and Clinical Gastroenterology. 2023;216(8): 9-23 (In Russ.) doi: 10.31146/1682-8658-ecg-216-8-9-23


Review

For citations:


Lazebnik L.B. Steatotic liver disease - an international interpretation of the concept an “umbrella” for all diseases of the hepatic parenchyma. Experimental and Clinical Gastroenterology. 2023;(8):24-26. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-216-8-24-26

Views: 480


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)